Gujarat Kidney And Super Speciality (NSE:GKSL) EPS (Basic): ₹2.32 (TTM As of Mar. 2026)


NSE:GKSL Gujarat Kidney And Super Speciality Ltd NSE:GKSL
18 GF Score
Price ₹129.23
! 3 Warning Signs
View Full Analysis

What is Gujarat Kidney And Super Speciality EPS (Basic)?

Gujarat Kidney And Super Speciality NSE:GKSL +0.83% 18 EPS (Basic) is ₹2.32 as of Mar. 2026. GuruFocus rates NSE:GKSL with a GF Score™ of 18/100. The stock has 3 warning signs investors should review.

Gujarat Kidney And Super Speciality's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹0.81. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.32.

Gujarat Kidney And Super Speciality's EPS (Diluted) for the three months ended in Mar. 2026 was ₹0.81. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.32.

Gujarat Kidney And Super Speciality's EPS without NRI for the three months ended in Mar. 2026 was ₹0.81. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 2.32.

During the past 12 months, Gujarat Kidney And Super Speciality's average EPS without NRIGrowth Rate was 108.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was 43.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Gujarat Kidney And Super Speciality's highest 3-Year average EPS without NRI Growth Rate was 43.50% per year. The lowest was 43.50% per year. And the median was 43.50% per year.

Gujarat Kidney And Super Speciality  (NSE:GKSL) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Gujarat Kidney And Super Speciality EPS (Basic) Related Terms

Gujarat Kidney And Super Speciality EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Gujarat Kidney And Super Speciality's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Kidney And Super Speciality EPS (Basic) Chart

Gujarat Kidney And Super Speciality Annual Data
Trend Mar23 Mar24 Mar25 Mar26
EPS (Basic)
0.84 1.23 1.19 2.49

Gujarat Kidney And Super Speciality Quarterly Data
Mar23 Mar24 Dec24 Mar25 Jun25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial 0.32 0.16 0.99 0.52 0.81
NSE:GKSL
18GF Score
Gujarat Kidney And Super Speciality Ltd NSE:GKSL
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gujarat Kidney And Super Speciality EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Gujarat Kidney And Super Speciality's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(154.969-0)/62.237
=2.49

Gujarat Kidney And Super Speciality's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(50.419-0)/62.246
=0.81

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹2.32 mean?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a EPS (Basic) of ₹2.32 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Gujarat Kidney And Super Speciality and its competitors.
Is Gujarat Kidney And Super Speciality's EPS (Basic) too high?
Gujarat Kidney And Super Speciality's current EPS (Basic) is ₹2.32. Overall, Gujarat Kidney And Super Speciality has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Gujarat Kidney And Super Speciality's EPS (Basic) compare to HCA and THC?
Gujarat Kidney And Super Speciality's EPS (Basic) of ₹2.32 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Healthcare Providers & Services company?
A good EPS (Basic) depends on the Healthcare Providers & Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Gujarat Kidney And Super Speciality and its competitors. Gujarat Kidney And Super Speciality's current EPS (Basic) is ₹2.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Kidney And Super Speciality stock overvalued right now?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a current EPS (Basic) of ₹2.32. The current EPS (Basic) is ₹2.32. Gujarat Kidney And Super Speciality's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Gujarat Kidney And Super Speciality (NSE:GKSL), the current EPS (Basic) is ₹2.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gujarat Kidney And Super Speciality Business Description

Other Exchanges 544666:India
Address Jetalpur Road, Gokak Mill Compound, Plot No. 1, City Sarve No. 1537/A, Jetalpur Bridge, Anand Nagar, Haripura, Alkapuri, Vadodara, GJ, IND, 390 020
Gujarat Kidney And Super Speciality Ltd is engaged in the business of operating a chain of mid-sized multispeciality hospitals in central Gujarat and providing integrated healthcare services, with a focus on secondary and tertiary care. It offers a range of healthcare services, including General Medicine, General Surgery, Laparoscopic Surgery, Urology, Cardiology, Nephrology, and many more. The company operates in a single segment, namely Medical and Healthcare Services. It generates a substantial portion of revenue from its services to inpatients. Geographically, it operates only in India.
18GF Score

Get the complete analysis for NSE:GKSL

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹129.23
Price